2020
DOI: 10.1016/j.hrtlng.2020.05.010
|View full text |Cite
|
Sign up to set email alerts
|

The health outcomes of inflammation and obesity in patients with heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 34 publications
1
9
0
Order By: Relevance
“…Most participants were in New York Heart Association functional class I or II (57%), had HF with reduced left ventricular ejection fraction (80%) and ischemic etiology of HF (62%), and were on angiotensin-converting enzyme inhibitors (79%), β-blocker (90%), diuretics (89%), antidyslipidemia (87%), and aspirin (61%) medications. The average HF duration was 4 years (range, 1-9 years), and the comorbidity score was 2.3 (range, [1][2][3][4][5][6][7][8][9][10][11]. Approximately half of the participants were obese.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Most participants were in New York Heart Association functional class I or II (57%), had HF with reduced left ventricular ejection fraction (80%) and ischemic etiology of HF (62%), and were on angiotensin-converting enzyme inhibitors (79%), β-blocker (90%), diuretics (89%), antidyslipidemia (87%), and aspirin (61%) medications. The average HF duration was 4 years (range, 1-9 years), and the comorbidity score was 2.3 (range, [1][2][3][4][5][6][7][8][9][10][11]. Approximately half of the participants were obese.…”
Section: Resultsmentioning
confidence: 99%
“…1,3,4 Despite optimal medical therapy to slow the progression of HF, patients continue to experience persistent or worsening HF symptoms. 1,2,5,6 Current guidelines indicate the need to incorporate comprehensive lifestyle modifications into the ongoing medical therapy immediately after the diagnosis of HF to decrease progression and symptom severity. 1,2,7 Clinical trials show that exercise training decreases HF symptoms, improves quality of life, prolongs survival, and lowers hospitalization rates.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Others proposed that inflammatory markers are better indicators of outcomes in HF. 13 The prevalence of adult obesity increased from 30.5% in 1999-2000 to 42.4% in 2017-2018. The prevalence of severe obesity (body mass index [BMI] ≥ 40 kg/m 2 ) almost doubled in 2017-2018 (9.2%), compared with 1999-2000 (4.7%).…”
mentioning
confidence: 99%
“…Marcks and colleagues 12 reported that obesity is a marker of less advanced disease, rather than having independent cardioprotective effects in HF. Others proposed that inflammatory markers are better indicators of outcomes in HF 13 . The prevalence of adult obesity increased from 30.5% in 1999–2000 to 42.4% in 2017–2018.…”
mentioning
confidence: 99%